LOC100041289 Inhibitors
LOC100041289 inhibitors like histone deacetylase inhibitors and Trichostatin A can impact gene expression profiles within cells, leading to changes in the expression of proteins including LOC100041289. DNA methyltransferase inhibitors like 5-Azacytidine can lead to widespread changes in the epigenetic landscape, potentially affecting the transcriptional regulation of LOC100041289. Compounds such as MG132 that inhibit the proteasome can prevent protein degradation, which may influence the levels of LOC100041289 if it is normally targeted for degradation.
Inhibitors of signaling molecules, such as LY294002 and Wortmannin for PI3K, Rapamycin for mTOR, PD98059 for MEK, SB203580 for p38 MAP kinase, SP600125 for JNK, Dasatinib for Src family kinases, and Imatinib for certain tyrosine kinases, can each lead to changes in the respective pathways that might impact LOC100041289 activity or stability. Additionally, cell cycle inhibitors like Palbociclib that target cyclin-dependent kinases can modulate the cell cycle, possibly resulting in changes in the expression or function of LOC100041289.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter gene expression, potentially affecting LOC100041289 if its expression is regulated by acetylation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can lead to DNA demethylation, potentially affecting gene expression of LOC100041289. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can prevent the degradation of proteins, potentially stabilizing LOC100041289 if it is normally degraded by the proteasome. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can disrupt PI3K/Akt signaling, potentially affecting LOC100041289 if it's involved in this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can affect protein synthesis and cell growth, potentially influencing LOC100041289 activity or expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which might affect the MAPK/ERK pathway and potentially the function of LOC100041289 if it's part of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially altering the activity of LOC100041289 if it is associated with the p38 MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that can modify the JNK signaling pathway, potentially influencing LOC100041289 function if it's linked to this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can disrupt PI3K-dependent signaling, potentially affecting LOC100041289's involvement in these pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor, potentially influencing LOC100041289 if it is regulated by Src kinase activity. | ||||||